Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0024530 (malaria)
 44,886 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

On many small Caribbean islands, two species of Anolis lizard coexist, but the two are typically very different in body size. The two Anolis of St. Maarten, however, are exceptional because they are similar in size and are known to be strongly competitive. One species, A. gingivinus, appears the stronger competitor and occurs throughout the island; the other, A. wattsi, is found only in the central hills. The malarial parasite Plasmodium azurophilum very rarely infects A. wattsi, but in some locations is very common in A. gingivinus. Wherever malaria infects A. gingivinus, A. wattsi is present, but wherever malaria is absent, only A. gingivinus occurs. This pattern of coincidence of malaria and coexistence of both Anolis is observed over distances of only a few hundred meters. The parasite infects both red and white blood cells of A. gingivinus and causes important pathology: immature erthrocytes increase in abundance, blood hemoglobin decreases, monocytes and neutrophils increase, and infected white cells are less likely to produce acid phosphatase. These results argue that malaria mediates competition between the two species and determines the present distribution of the lizards on St. Maarten. This kind of parasite-mediated competition could be common if susceptibility to parasitic infection varies among competitors. The distribution of malaria in the Anolis of Caribbean islands suggests this parasite can play an important role in Anolis community ecology.
 ...
PMID:Parasite-mediated competition in Anolis lizards. 2831 12

Type-2 phosphatidic acid phosphatase (PAP2) a member of PAP2 superfamily mediates the conversion of phosphatidic acid (PA) to diacylglycerol (DAG) and thus plays a pivotal role in numerous cellular signaling processes in diverse organisms. An elevated level of intracellular PA is detrimental for the cell and induces cell death. In this study we identified and characterized a PAP2 homologue in Plasmodium falciparum, PfPAP2 and further elucidated its significance in regulation of PA homeostasis in parasite life cycle. PfPAP2 is expressed in the blood stage and harbors the canonical acid phosphatase domain (APD) with signature motifs. PfPAP2 catalyzes the dephosphorylation of PA to produce DAG and inorganic phosphate (Pi). Propranolol, a generic inhibitor of PAP2, inhibited the phosphatase activity of PfPAP2 by binding to the active site of APD domain as evident by in silico docking and confirmed by surface plasmon resonance (SPR) analysis. Inhibition of native PfPAP2 by propranolol led to rise in intracellular PA mediating disruption of intracellular PA homeostasis in parasites. The propranolol mediated inhibition of PfPAP2 directed early secretion of a micronemal Perforin like Protein, PfPLP1 leading to untimely permeabilization and host cell egress. The merozoites following premature egress were non-invasive and were attenuated to invade erythrocytes and cannot continue next cycle growth. This study demonstrates that disruption of PA homeostasis can cause growth retardation in malaria parasites, and thus its master regulator, PfPAP2, can serve as a very good molecular target for antimalarial chemotherapeutic interventions.
 ...
PMID:Phosphatidic acid homeostasis regulated by a type-2 phosphatidic acid phosphatase represents a novel druggable target in malaria intervention. 3126 75


<< Previous 1 2